لاهور ۾ ڪورونا جي مريضن تي مليريا جي دوا جو تجربو ڪامياب، مريض صحتياب

 پنجاب جي مختلف اسپتالن ۾ ڪورونا جي مريضن تي مليريا جي دوا جو استعمال شروع ڪيو ويو. ميو اسپتال جي سي او او ڊاڪٽر اسد اسلم موجب  اسپتال ۾ ڪورونا ٽيسٽ مثبت ايندڙ مريضن تي مليريا جي دوا استعمال ڪئي پئي وڃي.

ميو اسپتال لاهور ۾ 15 ڏينهن ۾ 8 مريض صحتياب ٿي گهر وڃي چڪا آهن ۽ جيڪي مريض صحتياب ٿي ويا آهن ان  مٿان دوا جو نتيجو ظاهري طور تي ڪامياب رهيو.

ڊاڪٽر اسلم ٻڌايو ته چين ۾ مليريا جي دوا جي استعمال کان پوءِ هتي به فزيشن هي دوا استعمال ڪري رهيا آهن. پنجاب جي اسپتالن ۾ مليريا جي دوا پهريان کان موجود آهي.

ٻئي طرف پنجاب حڪومت جي ترجمان چيو آهي ته حڪومت مليريا جون 50 هزار کان وڌيڪ گوريون وڌيڪ اسٽاڪ ڪري ڇڏيون آهن. مارڪيٽ جي ذريعن موجب لاهور جي مارڪيٽن مان مليريا جون دوائون غائب ٿي چڪيون آهن.

واضح رهي ته آمريڪي ڊرگ اينڊ فوڊ ايڊمنسٽريشن ڪورونا جي مريضن لاءِ مشروط طور تي مليريا جي دوا استعمال ڪرڻ جي منظوري ڏني آهي.

Source: https://onlineindus.com/sindhi/97370

Views: 294

Comment

You need to be a member of PakAlumni Worldwide: The Global Social Network to add comments!

Join PakAlumni Worldwide: The Global Social Network

Pre-Paid Legal


Twitter Feed

    follow me on Twitter

    Sponsored Links

    South Asia Investor Review
    Investor Information Blog

    Haq's Musings
    Riaz Haq's Current Affairs Blog

    Please Bookmark This Page!




    Blog Posts

    Tata's Boardroom Crisis: Will it Impact Philanthropy in India?

    India's Tata Group is going through a major boardroom crisis. Noel Tata, the Chairman of the Tata holding company, has been removed from the Tata Group's board by N. Chandrasekaran, chairman of Tata Sons. Noel Tata has declared the decision illegal, a stance the board disputes. The crisis has been precipitated by a 2022 decision by India’s central bank to order the company to seek a stock market listing for Tata Sons, to comply with new rules governing systemically important…

    Continue

    Posted by Riaz Haq on October 1, 2026 at 6:30pm — 1 Comment

    Xi-Trump Summit: US-China G2 Rapprochement to Avoid Thucydides Trap

    The summit meeting of the leaders of China and the United States in Washington appears to signal a rapprochement between the two superpowers.  President Trump has repeatedly referred to what he calls "G2", without mentioning "G7" or "G20", the groups that include many more countries. This development is seen as positive for world peace but it diminishes India's significance as a "counterweight to China" and the benefits Indians expected to flow from the US-China confrontation in…

    Continue

    Posted by Riaz Haq on September 25, 2026 at 5:30pm — 5 Comments

    © 2026   Created by Riaz Haq.   Powered by

    Badges  |  Report an Issue  |  Terms of Service